MoleMap, a chain offering skin cancer diagnosis and treatment at more than 120 clinics across Australia and New Zealand, is weighing its future after several years of private equity ownership.
Michelle Aquilina is chief executive of MoleMap Australia and New Zealand.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com
